[Atrial arrhythmias of vagal or catecholaminergic origin: comparative effects of beta-blocker treatment and the escape phenomenon].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002395:Catecholamines / Q000502:physiology; D003937:Diagnosis, Differential; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006321:Heart / Q000294:innervation*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014630:Vagus Nerve / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011412:Propanolamines; D009248:Nadolol; D011433:Propranolol
Arythmies auriculaires d'origine vagale ou catécholergique. Effets comparés du traitement bêta-bloquant et phènomène d'èchappement.